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Isthmin(ISM)isa60kDasecreted-angiogenesisinhibitorthatsuppresses tumorgrowth inmouse anddisruptsvessel patterning
in zebraﬁsh embryos. It selectively binds to alphavbeta5 (avb5) integrin on the surface of endothelial cells (ECs), but the
mechanism of its antiangiogenic action remains unknown. In this work, we establish that soluble ISM suppresses in vitro
angiogenesis and induces EC apoptosis by interacting with its cell surface receptor avb5 integrin through a novel ‘RKD’ motif
localizedwithinitsadhesion-associateddomaininMUC4andotherproteinsdomain.ISMinducesECapoptosisthroughintegrin-
mediated death (IMD) by direct recruitment and activation of caspase-8 without causing anoikis. On the other hand, immobilized
ISM loses its antiangiogenic function and instead promotes EC adhesion, survival and migration through avb5 integrin by
activating focal adhesion kinase (FAK). ISM unexpectedly has both a pro-survival and death-promoting effect on ECs depending
on its physical state. This dual function of a single antiangiogenic protein may impact its antiangiogenic efﬁcacy in vivo.
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Angiogenesis, formation of new blood vessels from pre-
existing capillaries, is critical for embryonic development,
wound healing, reproduction, as well as tumor progression
and metastasis.
1 Angiogenesis inhibitors hence offer new
promises as therapeutic agents for cancer therapy. In vivo,
angiogenesis is believed to be regulated by a balance of pro
and antiangiogenic factors. Although a number of endogen-
ous angiogenesis inhibitors such as thrombospondin-1
(TSP-1) and endostatin have been discovered, the full
spectrum of angiogenesis inhibitors in vivo and how they
regulate angiogenesis remain to be fully elucidated.
2
Isthmin (ISM), a 60kDa secreted matricellular protein, was
originally identiﬁed as a gene highly expressed in the
midbrain-hindbrain organizer in Xenopus embryos.
3 It con-
tains a centrally located thrombospondin type 1 repeat (TSR)
domain and a C-terminal domain called adhesion-associated
domain in MUC4 and other proteins (AMOP). We recently
reported that ISM is a novel endogenous angiogenesis
inhibitor with functions in both physiological and pathological
angiogenesis.
4 It suppresses multiple aspects of in vitro
angiogenesis including endothelial cell (EC) capillary network
formation on Matrigel and EC proliferation. It also induces EC
apoptosis. In mice, overexpression of ISM in B16 melanoma
cells inhibited tumor growth and angiogenesis. Knockdown of
ISM in zebraﬁsh embryos led to abnormal intersegmental
vessel (ISV) formation in the trunk.
4 Although ISM was shown
to selectively bind to alphavbeta5 (avb5) integrin, the
mechanism of its antiangiogenic action is still largely unclear.
To decipher ISM’s mechanism of action, we addressed the
following questions in this work: (1) Does avb5 integrin
mediate ISM’s antiangiogenic activities, such as inducing
apoptosis? (2) How does ISM induce EC apoptosis?
(3) Would ISM generate similar anti-endothelial effects in
bothsolubleandanchoredconditions?(4)WouldISMfunction
as a cell adhesion molecule? If yes, how does it compare with
other cell adhesion molecule in the extracellular matrix
(ECM)? Using both neutralizing antibody as well as RNAi
gene expression knockdown, we demonstrated that suppres-
sing integrin avb5 could stiﬂe apoptosis induced by ISM and
relieve ISM’s inhibition of EC proliferation. We further
established that ISM induces EC apoptosis through integrin-
mediated death (IMD) by activating caspase-8 without
causing anoikis. Although soluble ISM potently induces
apoptosis, immobilized ISM loses the proapoptotic activity
and instead promotes EC adhesion, survival and haptotactic
migration. These results suggest that the matricellular protein
ISM in different physical state can trigger different intracellular
signaling pathways and generate different biological effects
through the same integrin receptor. It can function as
an integrin agonist as well as an antagonist. This is different
fromclassicalECMintegrinligandssuchasvitronectin(VN)or
ﬁbronectin (FN).
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Soluble ISM inhibits angiogenesis and induces EC
apoptosis through avb5 integrin. We have previously
reported that soluble ISM produced from E. coli functions
as an angiogenesis inhibitor, inhibiting EC tube formation,
inducing EC apoptosis and suppressing vascular endothelial
growth factor (VEGF)-stimulated EC proliferation in a dose-
dependent manner.
4 We also found that ISM selectively
binds to avb5, but not other integrins expressed in ECs.
4 We
show here that recombinant ISM protein produced from
cultured mammalian cells (HEK293T) has similar
antiangiogenic and apoptosis-induction activity (Supplemen-
tary Figure S1). Because of cost-effective production,
recombinant ISM made from bacteria is used in this study.
As avb5 integrin is a cell surface receptor of ISM, we wish to
determine whether ISM inhibits angiogenesis and induces
apoptosis through this integrin. In ECs (human umbilical vein
endothelial cells, HUVEC) used in this study, integrin b3o rb5
subunit only pairs with av subunit, with avb3 expressed at a
much higher level than avb5.
5,6 Knockdown of b3o rb5
integrin subunit expression in ECs had no effect on cell
adhesion on gelatin, FN or collagen I (data not shown),
possibly due to the presence of b1 integrins such as a5b1i n
these cells. It is known that b1 integrin mediate cell adhesion
to gelatin, FN and collagen I.
7 Hence the effect of knockdown
of b3o rb5 integrin subunit expression on ISM-mediated
inhibition of EC tube formation and induction of apoptosis was
carried out in cells seeded on gelatin. As shown in Figure 1a,
introduction of siRNA signiﬁcantly reduced b3 and b5-integrin
expression up to 70% in ECs. However, only knockdown of
b5-integrin expression alleviated ISM-mediated inhibition of
tube formation (Figure 1b). Similarly, ISM-induced EC
apoptosis was selectively suppressed by b5, but not b3-
knockdown (Figure 2a). In the absence of ISM, knockdown of
these integrins did not induce apoptosis. Similarly, only
knockdown of b5-integrin expression signiﬁcantly rescued
ISM-mediated inhibition of VEGF-induced EC proliferation
(Figure 2b). These results demonstrate that avb5 integrin has
an essential role in ISM-mediated angiogenesis inhibition and
apoptosis.
As avb5 is essential for ISM-induced apoptosis, the amount
offreeavb5availableforISMbindingshouldcorrespondtothe
extentofECapoptosis.InECsattachedonVN-orISM-coated
surface, both ligands of avb5 integrin, the free avb5 available
for soluble ISM binding are reduced, comparing with ECs
attached on FN-coated surface (Figure 2c), most likely due to
avb5 occupancy by VN or ISM. Correspondingly, soluble ISM
induced only marginal apoptosis in ECs attached on VN and
ISM, compared with signiﬁcant apoptosis with ECs attached
on FN (Figure 2d).
Together, these results demonstrate that soluble ISM
suppresses angiogenesis and induces EC apoptosis through
interacting with avb5 integrin on EC surface without causing
anoikis. The extent of ISM-induced apoptosis depends on the
number of free avb5 integrin on EC surface that are available
for soluble ISM binding.
Soluble ISM induces EC apoptosis through IMD. It is
known that certain cyclic RGD peptides
8 or non-peptide RGD
mimetics
9 induce EC detachment from adhered surface
(de-adhesion) through binding to integrins, and hence
causing apoptosis through anoikis. To determine whether
ISM induces EC apoptosis through anoikis, we examined
whether ISM induces detachment of adherent ECs. The
adhesion of ECs on different immobilized ECM proteins is
mediated by distinct integrins. For example, EC adhesion to
VN is mediated primarily by avb3 and avb5 integrins,
whereas EC adhesion to FN occurred mainly through a5b1
integrin.
5 As shown in supplementary (Supplementary
Figure S2), ISM added into the culture media did not induce
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Figure 1 ISM inhibits in vitro angiogenesis through avb5 integrin. (a) Transient transfection of b3 and b5 siRNA effectively knocked down their expression in ECs. Same
amount of corresponding scrambled siRNA are transfected as control. (b) Only knockdown of b5-integrin expression abolished the anti-tube formation activity of ISM
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Cell Death and Diseasede-adhesion of ECs plated on FN- or VN-coated surface,
regardless of whether its receptor avb5 integrin is bound by a
ligand (VN) or not (FN). Under the same condition, ISM
potently induced EC apoptosis (Xiang et al.
4 and Figure 2a).
We previously established that ISM induces EC apoptosis
through a caspase-dependent pathway.
4 To further decipher
the mechanism of ISM-induced apoptosis, we used speciﬁc
inhibitors for caspase-3, -8 and -9 to block the extrinsic and
intrinsic apoptosis pathways. As shown in Figure 3a, caspase-3
and-8inhibitorseffectivelypreventedISM-inducedapoptosis,
whereas caspase-9-speciﬁc inhibitor had no effect.
Agradualactivationofcaspase-8andcaspase-3underISM
treatment was observed (Figure 3b). The active form of
caspase-8 (20kDa) was ﬁrst detected at 4h post ISM
treatment, whereas activated caspase-3 was ﬁrst detected
after 16h ISM treatment. No cleaved form of caspase-9 was
detected even after 24h treatment. As a hallmark indicator of
apoptosis, the cleaved form of poly ADP ribose polymerase
(PARP, 87kDa) was also found to gradually increase
(Figure 3b). Activation of caspase-8 and caspase-3 by ISM
depends on avb5 integrin as knockdown of b5 integrin by
siRNA-suppressed ISM-induced caspase activations and
PARP cleavage (Figure 3c). These results established that
ISM induces apoptosis via the extrinsic apoptosis pathway
through caspase-8 activation.
It has been previously reported that unligated or antag-
onized integrin can cluster on cell surface and subsequently
recruit caspase-8 to plasma membrane, where it becomes
activated in a death receptor-independent manner, a phe-
nomenon termed IMD.
10 To determine if ISM initiates
apoptosis through IMD, co-immunoprecipitation was per-
formed to examine the interaction between avb5 integrin
and caspase-8. As shown in Figure 3d, ISM induced the
association of procaspase-8 (55kDa) and activated caspase-
8 (20kDa)with avb5 integrin. A Fas antagonist did not prevent
ECs from ISM-induced apoptosis, indicating that Fas is not
involved in ISM-induced cell death (Supplementary Figure
S3). Correspondingly, Fas-associated protein with death
domain (FADD) was not detected in ISM-induced co-
immunoprecipitate sample (data not shown), indicating that
FADD is not involved. We therefore conclude that soluble ISM
act as a avb5-integrin antagonist and induce EC apoptosis
through IMD.
We found that soluble ISM induced integrin clustering
(Figure 3E), with EC bound ISM (green) and integrin
b5-subunit (red) co-localized in cell periphery in clusters.
The clustered integrin may be responsible for the recruitment
and activation of caspase-8.
Immobilized ISM promotes EC survival and
migration. After its secretion, ISM could potentially exist in
different physical states in vivo, such as immobilized in the
ECM of a tissue or soluble in circulation. Indeed, we detected
ISM in the mouse plasma (98nM) and the ECM (in Matrigel,
91.5nM). Interestingly, when ISM was mixed with Matrigel, it
lost the ability to inhibit EC tube formation. Soluble ISM at
1mM in culture medium completely abolished EC tube
formation on Matrigel, whereas immobilized ISM in Matrigel
had no effect on tube formation even at 3mM (Figure 4).
Integrin-mediated cell attachment on immobilized ECM
ligands such as FN or VN results in cell spreading, focal
adhesion and actinstress ﬁber formation, aswell asactivation
of focal adhesion kinase (FAK).
11 To determine if immobilized
ISM could also function as a cell adhesion molecule and
support EC survival, we plated ECs onto ISM-coated surface.
As shown in Figure 5a, immobilized ISM supported EC
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Figure 2 ISM induces EC apoptosis through avb5 integrin. (a) Knockdown of
b5, but not b3 integrin, suppressed ISM-induced apoptosis. (b) Knockdown of b5
integrin rescued ISM-suppressed proliferation. (c) More free avb5 integrins are
available in ECs growing on FN-coated surface. VN, vitronectin; ISM, isthmin; FN,
ﬁbronectin. (d) ISM induces more extensive apoptosis in ECs grown on FN-coated
surface
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Cell Death and Diseaseadhesion in a dose-dependent and saturable manner. ECs
spread on ISM-coated surface in a similar fashion to VN-
coated surface (Figure 5B, panels a and b).The adhesionand
spreadingwascompletelyabolishedinthepresenceof10mM
EDTA, consistent with the fact that divalent cations are
essential for integrin-mediated cell adhesion
11 (Figure 5B,
panels c and d). ECs attached on ISM-coated surface
proliferate at similar rate, compared with ECs attached on
VN or gelatin (data not shown). Immobilized ISM also induced
actin stress ﬁber formation and integrin clustering, similar to
VN (Figure 5B, panels e–h). Therefore, immobilized ISM
supports EC adhesion and survival as a cell adhesion
molecule.
We further demonstrated that ECs adhere to ISM-coated
surface through avb5 integrin, as avb5 blocking antibody
blocked 85% of this adhesion, whereas control IgG or avb3
blocking antibody had no blocking activity (Figure 5c). Anti-av
or anti-b5-subunit antibody also blocked EC adhesion to
ISM-coated surface by 56 and 61%, respectively, whereas
anti-b1 and anti-b3 antibody had no effect. Collectively, these
results conﬁrmed that avb5 integrins mediate EC adhesion to
ISM and serves as receptor for immobilized ISM. In
comparison, EC attachment to collagen I was inhibited
by anti-b1(50%), or attachment to VN was inhibited by
anti-avb3(51%) and anti-avb5(29%), respectively, consistent
withthe ligand-receptor speciﬁcity(Supplementary Figure S4,
A and B).
Knockdownofeitherb3orb5-integrinsubunitexpressionby
50-70% through siRNA signiﬁcantly suppressed cell adhesion
on VN-coated surface (Figure 5d), with b3-knockdown having
more potent suppression (Figure 5d). This is consistent with
the much higher level of b3 integrin expression in HUVECs
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Cell Death and Diseaseand the fact that avb3 is the main VN receptor.
6,12 In contrast,
only knockdown of b5 integrin reduced cell adhesion to ISM-
coated surface, consistent with ISM as a avb5 speciﬁc ligand
(Figure 5e). Correspondingly, knockdown of b3o rb5 integrin
subunits had no effect on EC adhesion to type I collagen, FN
and gelatin (data not shown).
FAK is an important mediator of cell survival, proliferation
and migration.
13 Integrin clustering leads to FAK phosphor-
ylation and subsequent recruitment to focal adhesions.
14 The
most crucial site for FAK activation is Y397, which is an Src-
binding site. Comparing with cells in suspension, immobilized
ISM induced FAK Y397 phosphorylation, similar to immobi-
lized VN (Figure 6a). Notably, immobilized ISM no longer
induces EC apoptosis and present similar basal level
apoptosis as immobilized VN, suggesting that immobilized
ISM functions as an integrin agonist and transmit positive
intracellular signals (Supplementary Figure S5).
ECs migrate towards a higher concentration of anchored
cell adhesion molecule, a phenomenon termed haptotaxis.
Immobilized ISM induced EC haptotactic migration in a
concentration-dependent manner with similar potency as FN
(Figure 6b). This haptotactic migration is blocked by anti-av,
anti-b5 and anti-avb5 antibodies, but not by anti-b1, anti-b3o r
anti-avb3 antibodies (Figure 6c), indicating avb5 as the
mediator of this function.
Altogether,theaboveresultsrevealedthatimmobilizedISM
no longer induces apoptosis, but serves as an adhesion
molecule for ECs and an agonist of avb5 integrin. It functions
in similar fashion as VN or FN, inducing avb5 integrin
clustering and actin stress ﬁber formation, promotes EC
adhesion, survival, haptotactic migration and stimulates FAK
activation.
ISM binds to avb5 integrin through a novel ‘RKD’
motif. Using a solid-phase ELISA-based binding assay, we
determined that ISM binds avb5 integrin with a Kd around
40mM, in the range of integrin ECM ligand binding afﬁnities
(Supplementary Figure S6). We have previously determined
that ISM binds to avb5 integrin through its C-terminal AMOP
domain, and the AMOP domain alone can inhibit EC tube
formation in vitro.
4 However, there is no ‘RGD’ sequence
within the AMOP domain of ISM. To determine how ISM
binds to avb5 integrin, we produced recombinant proteins,
corresponding to overlapping N- and C-terminal truncations
of AMOP domain (Figure 7a). ECs attached to AMOP-N
coated surface with similar efﬁcacy as the intact AMOP
domain, whereas AMOP-C could not support EC attachment
at all (Figure 7b). It has been reported that substitution of G
for K in the RGD motif of a 12 residue synthetic hepatitis-A
peptide did not change the physiochemical properties of the
peptide.
15 However, it is not known if ‘RKD’ can function as
an integrin binding motif. In AMOP-N, there is an ‘RKD’ motif
at amino acids 315–317. We mutated the ‘KD at 316–317
position to AA’ and produced the mutant AMOP
KD316AA
protein in the intact AMOP background (Figure 7a). As
shown in Figure 7b, AMOP
KD316AA completely lost the ability
to support EC adhesion. Furthermore, AMOP
KD316AA also
lost the ability to inhibit EC tube formation on Matrigel
(Figure 7c). These results demonstrate that ISM binds to EC
surface avb5 integrin through a novel ‘RKD’ motif located in
its C-terminal AMOP domain. This motif has a critical role in
the antiangiogenic as well as pro-survival functions of ISM.
‘RKD’ is therefore a novel integrin-binding motif, which binds
avb5, but not avb3 integrin.
Discussion
In this work, we demonstrated that the recently identiﬁed
matricellular angiogenic inhibitorISMfunctions throughitscell
surface receptor avb5 integrin. Although soluble ISM sup-
presses EC tube formation and induces EC apoptosis as an
integrin antagonist, immobilized ISM functions as an integrin
agonist and promotes cell survival and migration. The
antiangiogenic activity of ISM is lost when ISM is immobilized
in ECM. We demonstrated that mouse ISM is present in
soluble (plasma) and immobilized form (extracellular matrix),
thus its dual activity may have an important role in vivo.
We also identiﬁed a novel avb5-integrin-binding site ‘RKD’
located in the AMOP domain of ISM. Loss of avb5 binding
through point mutations of this ‘RKD’ motif obliterated the
antiangiogenic activity of ISM in vitro and abolished the ability
ISM in Medium
  100 nM
500 nM 500 nM
100 nM
1 M1   M
3 M
 
Control
ISM in ECM Gel
Figure 4 Immobilization of ISM by ECM abolished its anti-tube formation
activity. Recombinant ISM was added into culture medium (left) or mixed into
Matrigel (right). The concentrations of ISM were labeled in the panels. Scale bar
represents ? mm. Control indicates culture medium (containing 2% FBS)
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Cell Death and Diseaseof ISM to support EC adhesion. Therefore, integrin avb5 has
an essential role in the antiangiogenic as well as pro-survival
functions of ISM. This dual function of ISM through the same
cell surface integrin receptor and the intracellular signaling
pathways involved are summarized in Figure 8. As avb5
integrin is upregulated in tumor blood vessels, ISM most likely
inhibits tumor angiogenesis through this integrin in vivo.
Similar to VN, immobilized ISM promoted EC attachment
and spreading, integrin clustering, actinstress ﬁber formation,
FAK activation and EC haptotactic migration (Figures 5
and 6). The clustering of integrins upon ECM engagement is
known to transmit positional cues from ECM to intracellular
signaling cascades that promote cell survival.
14 Both
neutralizing antibody to avb5 integrin, as well as siRNA
knockdown of b5 integrin, abrogated EC adhesion to
immobilized ISM, demonstrating that immobilized ISM is an
avb5 integrin agonist (Figure 5).
Different from VN, soluble ISM inhibits in vitro angiogen-
esis,inducesECapoptosisandsuppressesECproliferationin
an avb5 integrin-dependent manner (Figures 1 and 2).
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Figure 5 ImmobilizedISMpromotesECadhesionthroughavb5integrin.(A)ECsattachto ISM-coatedsurface ina dose-dependent andsaturablemanner.(B)Similarto
VN, ISM supports EC adhesion and spreading, induces integrin clustering and actin stress ﬁber formation. Cell spreading in the absence or presence of EDTA are
shown in phase contrast micrographs (panels A–D, scale bar: 40mm). Actin stress ﬁbers (red) and b5 integrin clustering (green) are shown in panels E–H (scale bar: 20mm).
(C) ISM mediates EC adhesion through avb5 integrin. (D) Knockdown of b3 and b5 integrin suppresses EC adhesion to VN. (E) Knockdown of b5 integrin suppresses
EC adhesion to ISM
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Cell Death and DiseaseKnockdown of b5, but not b3 integrin in ECs rendered ISM
inactive in inhibition of tube formation and induction of
apoptosis. Correspondingly, ISM induced more extensive
apoptosis in ECs cultured on non-avb5 ligand-coated surface
such as FN (Figure 2d), due to the higher amount of free avb5
integrin available for soluble ISM binding in cells adhered to
FN comparing with VN or ISM (Figure 2c). As ISM binds to
avb5 integrin with a low afﬁnity (Kd around 40mM), it cannot
effectivelydisplaceboundVNbycompetitivelybindingtoavb5
integrin (Supplementary Figure S6).
We further demonstrated that ISM induces apoptosis
throughIMDbyrecruitingcaspase-8totheplasmamembrane
and activating caspase-8 in a Fas-independent manner. Both
the zymogen and active forms of caspase-8 are found in the
avb5 protein complex upon ISM induction of apoptosis
(Figure 3d). Soluble ISM therefore serves as an integrin
antagonist and transmits a direct death signal involving
caspase-8 and caspase-3. This is similar to IMDs induced
by RGD containing avb3 integrin antagonist echistatin or
overexpression of unligated avb3 integrins.
10,16 In contrast to
previous report that b5 integrin is non-apoptotic,
10 our results
provide the ﬁrst evidence that b5 integrin also mediates IMD.
Both soluble and immobilized ISM induces avb5-integrin
clustering (Figures 3E and 5B). Although clustering of
unligated or antagonized integrins is known to induce
apoptosis in adherent cells, clustering of agonized integrin
promotes cell survival.
17 Whether soluble and immobilized
ISM induce different mode of integrin clustering which lead to
different interactions with focal adhesion proteins and activate
different intracellular signaling pathways warrant further
investigation.
The full spectrum of Ism’s physiological role is not clear at
this moment. Our preliminary investigation indicated that Ism
is expressed at a signiﬁcantly higher level in lung, comparing
with other tissues (Supplementary Figure S7). Future
investigation by immunohistochemistry is needed to reveal
how ISM is presented to ECs in vivo.
The phenomenon that an endogenous antiangiogenic
protein in different physical state (soluble versus immobilized)
carries out contrasting functions in angiogenesis may impact
the in vivo efﬁcacy of the antiangiogenic protein. This dual-
function characteristic may also exist in other endogenous
antiangiogenic proteins. For example, immobilized endostatin
has been reported to support EC adhesion in an integrin-
dependent manner, whereas soluble endostatin inhibits
integrin-dependent cell functions such as cell migration and
induces apoptosis.
18 It seems that integrin can promote or
suppress apoptosis depending on the physical state of its
ligand. This characteristic places integrin as a type of
dependence receptors that require immobilized ligands to
promote cell survival, whereas soluble ligands act as
antagonists inducing IMD.
16,19 In contrast to ISM, ECM
adhesion molecules such as VN or FN, which serve as
integrin agonists when immobilized, do not function as
antagonists to trigger apoptosis in soluble state.
Concluding remarks. In this work, we demonstrated that
the endogenous angiogenesis inhibitor ISM could function as
either antagonist or agonist of avb5 integrin and modulate EC
apoptosis and survival. Although immobilized ISM promotes
EC survival and haptotactic migration, soluble ISM
suppresses EC tube formation and induces EC apoptosis
through IMD. This study also identiﬁed a novel ‘RKD’ motif
within the AMOP domain of ISM, which mediates the speciﬁc
binding of ISM to avb5, but not avb3. As other endogenous
angiogenesis inhibitor proteins may behave in similar
fashion, it is conceivable that an antiangiogenic protein
may inhibit or promote angiogenesis depending on its
physical state in vivo. This may impact on the in vivo
efﬁcacy of the antiangiogenic proteins as anticancer drugs.
Materials and Methods
Cell culture and recombinant protein production. Endothelial cells
(ECs) used in this work are HUVECs. Fresh umbilical cords were collected from
consented maternal ward patients at the National University Hospital according to
theprotocol(DSRBC/00/553),whichisapprovedbySingaporeNationalHealthcare
Group’s Domain-Speciﬁc Review Board (DSRB) ethics approval committee. ECs
were cultured in CSC complete medium (Cell System Corporation, Kirkland, WA,
USA). Only cells of passages 4–8 were used in experiments.
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Figure 6 Immobilized ISM activates FAK and promotes EC haptotactic
migration. (a) Immobilized ISM activates FAK Y397 phosphorylation in similar
fashion as immobilized VN. S, cells in suspension. (b) ISM dose-dependently
promotesEChaptotacticmigrationwithsimilarpotencyasFN.(c)ISMpromotesEC
haptotactic migration through avb5 integrin
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Cell Death and DiseaseCell attachment assays. The assays were performed as described
previously, with minor modiﬁcations.
20 96-well plates (Nunc, Rochester, NY,
USA)werecoatedwiththeindicatedconcentrationsofISMorECMproteins(Sigma,
St. Louis, MO, USA) at 41C overnight. Nonspeciﬁc binding sites were blocked with
1% BSA. Subconﬂuent ECs were harvested and suspended in CSC basal medium.
Cells (2 10
4) were plated to each well and allowed to attach for 60min at 371Ci n
CO2 incubator. In some experiments, ECs were pre-incubated for 30min with
integrin-speciﬁc antibodies (av antibody (clone M9), b1 antibody (clone P4C10), b3
antibody (clone 25E11), b5 antibody (clone E19), avb3 antibody (clone LM609),
avb5 antibody (clone P1F6)) (Millipore, Billerica, MA, USA) or control IgG prior to
their addition to the wells. After removal of the nonattached cells by washing with
PBS, attached cells were ﬁxed with 10% formalin (Sigma) and stained with 0.2%
crystal violet. The crystal violet was extracted by 10% acetic acid and cell
attachment was quantiﬁed by measuring the absorbance of eluted dye at 595nm
with a microplate reader.
Apoptosis assays. ECs (1 10
4 cells per well) in 96-well plate were starved
in basal CSC medium containing 2% FBS overnight before treated with 1mM ISM
and 15ng/ml VEGF for 24h. Apoptosis was determined by measuring cytosolic
oligonucleosome-boundDNAusingaCellDeathELISAkit(RocheDiagnosticsAsia
Paciﬁc, Singapore). Caspase inhibitors Z-DEVD-FMK (caspase 3 inhibitor),
Z-IEDT-FMK (caspase 8 inhibitor), Z-LEHD-FMK (caspase 9 inhibitor) and Kp7-6
(Fas antagonist) (Merck, Singapore) were added to cells 1h prior to treatment with
ISM and VEGF.
Cell proliferation assay. ECs or siRNA transfected ECs (2 10
4 per well)
were seeded in a gelatin-coated 96-well plate with CSC complete medium for 24h
at 371C and 5% CO2. Cells were starved with CSC basal medium supplemented
with 2% FBS overnight. Then 1mM ISM and 15ng/ml VEGF were added at the
beginning of the proliferation assay. ECs were allowed to proliferate for 24h and
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0.2% Gelatin 1μM AMOP 1μM AMOP-N 1μM AMOP-C 1μM AMOPKD316AA 1%BSA
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Figure 7 Identiﬁcationoftheavb5integrin-bindingsiteinISM.(a)SchematicdiagramsshowingthetruncatedISMproteinfragmentsproducedasrecombinantproteinsin
E. coli. Numbers refer to the amino acid position in the full-length secreted ISM protein. The positon of KD316AA mutation is indicatedby the arrowhead. The black triangle at
the right end of each truncated protein represent His-tag. (b) EC adhesion to various ISM protein fragments compared with 0.2% gelatin. 3% BSA was used as the negative
control. (c) KD316AA mutation abolished the anti-tube formation activity of ISM
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Cell Death and Diseaseproliferation was determined by BrdU labeling (Millipore), according to
manufacturer’s instruction.
ELISAmeasurementoffreeavb5integrin. Atotalof96-wellplateswere
coated with VN (50mg/ml), FN (50mg/ml) and ISM (1mM) at 371C for 2h.
Nonspeciﬁc binding sites were blocked with 1% BSA in PBS for 2h at room
temperature. HUVECs (2 10
4 cells) were seeded into each well and allowed to
attach overnight. After removal of the nonattached cells by washing with PBS, ECs
were ﬁxed and blocked with 3% BSA prior to incubating with anti-avb5 antibody
(clone P1F76, Santa Cruz, Santa Cruz, CA, USA) for 1h. Detection of integrin was
achieved by anti-mouse IgG-HRP and developed with TMB (3,30,5,50-
tetramethylbenzidine) (Dako, Glostrup, Denmark) for 15min. The reaction was
stoppedwiththeadditionof50ml1MH 2SO4.Theabsorbancewasthendetermined
at 450nm.
Immunoﬂuorescence staining. ECs were plated for 2h on 96-well plates
coated with 20mg/ml of either VN or ISM. Cells were rinsed with PBS twice, ﬁxed
with 4% paraphormaldehyde in PBS, permeabilized with 0.1% Triton X-100 in PBS
for10minandblockedwith3%BSAfor1hatroomtemperature.Cellswerestained
with rhodamine-conjugated phalloidine (actin stress ﬁbers) or goat anti-b5 antibody
(SantaCruz)withFITC-labeledrabbitanti-goatIgG(Invitrogen,Carlsbad,CA,USA)
and counter-stained with DAPI (Sigma). For ISM binding to ECs, cells were
incubated with ISM for 1h at 371C and 5% CO2 before they are ﬁxed and stained
with mouse anti-His tag (sc-57598, Santa Cruz) and goat anti-b5 (sc-5401, Santa
Cruz) in 3% BSA for 1h. ISM and b5 integrin were then visualized with a mix of
Alexa Fluor 488 rabbit anti-mouse IgG and Alexa Fluor 568 rabbit anti-goat IgG
(Invitrogen). Fluorescence images were obtained with a Zeiss laser scanning
confocal microscope system (Carl Zeiss South East Asia, Singapore).
RNAi mediated gene silencing. siRNAs were purchased from 1st BASE
(Singapore): siRNA targeting human b3 integrin subunit mRNA (50-CAAGCCUG
UGUCACCAUAC-dTdT-30); human b5 subunit integrin mRNA (50-GCUCGCAG
GUCUCAACAUA-dTdT-30); and a random sequence control siScramble
(50-GACGUGGGACUGAAGGGGU-dTdT-30) were as described before.
21
Determination of caspase activation by immunoblot. Activation of
caspases 3, 8, and 9 was determined as a function of procaspase cleavage.
22 ECs
(1 10
5/ml) were incubated with ISM (1mM) and VEGF (15ng/ml) for 24h.
Caspase activation and PARP cleavage were analyzed at 0, 2, 4, 8, 16 and 24h
post ISM-treatment. Cell lysates were separated by SDS-PAGE and probed with
antibodies to caspase 3 (R&D systems, Minneapolis, MN, USA), caspase 8,
caspase 9, PARP (Millipore).
Co-immunoprecipitation. ECs were incubated with 1mM ISM for 16h at
371C, 5% CO2. After removing the unbound ISM, cells were washed,lysed and cell
lysates were incubated with anti-avb5 antibody, control IgG and protein A/G
Sepharose beads (Santa Cruz) for 2h at 41C. The precipitates were resolved and
analyzed for the presence of caspase-8 or FADD by immunoblotting.
Cell haptotaxis assay. Haptotactic cell motility was measured by using 8mm
cell culture inserts, as previously described.
23 The undersurface of the membrane
ﬁlter was pre-coated with serial concentration of BSA, ISM or FN. ECs (1 10
6
cells/ml) were added to each insert. The cells were allowed to migrate for 6h at
371C and 5% CO2 before being ﬁxed and stained with crystal violet. Cell migration
was quantiﬁedby measuringthe absorbanceof elutedcrystal violet at 560nm.Anti-
integrin antibodies were used at 10mg/ml in the antibody-neutralization
experiments.
Determination of integrin binding site of ISM. AMOP-N and AMOP-C
region were cloned into pET-M vector (as described in reference 4) using the
following primers: AMOPF1EcoRl: CCGGAATTCCGGCTGCTTGCGGG AAGTGA
GGAGT;AMOPR1Xhol:CCGCTCGAGCGGCTCCAGGGACAGCATAGAGCGGA;
AMOPF2EcoRl:CCGGAATTCCGGTGCATCCGCTCTATGCTGTCCCT;AMOPR2Xhol:
CCGCTCGAGTCGGTCTGGCTTCTTGGAACTGTTTG.Thepointmutantsdenoted
AMOPKD316AA was obtained from a pET-M-AMOP plasmid using site-directed
mutagenesis procedures (Stratagene, La Jolla, CA, USA). The recombinant
proteins were expressed in E.coli (BL21DE3) and puriﬁed using Ni-NTA afﬁnity
chromatography in6Murea,accordingto themanufactures’instructions(Promega,
Madison,WI,USA).Theproteinswerethenfurtherpuriﬁedbyreverse-phaseHPLC.
Protein concentration was determined using BioRad Bradford assay reagent
Immobilized ISM
Ligated αvβ5
FAK
Cell Migration/Survival Pathways
Active caspase 8
Active caspase 3
Apoptosis Life
Recruitment of
Procaspase 8
IMD
Procaspase 8
Soluble ISM
Antagonized αvβ5
Figure8 SchematicillustrationofthedualfunctionsofISM.(a)ImmobilizedISMservesasintegrinagonisttomediatecellsurvival/migrationbyactivatingFAK.(b)Soluble
ISM induces cell apoptosis through IMD (direct activation of caspase-8). ‘?’ indicates the unresolved question if additional molecules are involved in the integrin–caspase-8
complex formation
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Cell Death and Disease(BIORAD, Hercules, CA, USA). Cell attachment assays were then used to
determine the ability of various protein fragments to support EC adhesion, as
described in the above section.
Statistical analysis. All data values were reported as mean±S.E.M.
Statistical differences were determined using the Student’s t-test. P-values of
0.05 were considered to be statistically signiﬁcant.
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